Ferrer Internacional S.A. Patent applications |
Patent application number | Title | Published |
20160106763 | ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES - The present invention relates to a pharmaceutical composition which includes a HMG-CoA reductase inhibitor, in particular, a statin and acetylsalicylic acid in a manner to minimize interaction of acetylsalicylic acid with the statin, for use in the prevention or treatment of cardiovascular diseases. | 04-21-2016 |
20140187578 | Pharmaceutical Topical Compositions - The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream. | 07-03-2014 |
20130331610 | Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates - The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R | 12-12-2013 |
20130131378 | PROCESS FOR PREPARING 4-NITRO-OXY-METHYL-BENZOIC ACID - This invention relates to a new process for preparing 4-nitro-oxy-methyl-benzoic acid, comprising the following steps: a) reaction of 4-chloromethyl-benzoic acid with silver nitrate and in the presence of an acid as a catalyst in acetonitrile at reflux temperature, followed by cooling and adding of a polar aprotic solvent; b) separation of the silver salts by filtration, followed by washout with a polar aprotic solvent; c) precipitation of the 4-nitro-oxy-methyl-benzoic acid with water from the filtrate obtained in step b); and d) drying of the 4-nitro-oxy-methyl-benzoic acid. | 05-23-2013 |
20130040989 | 1-CYCLOPROPYL-8-METHYL-7-[5-METHYL-6-(METHYLAMINO)-3-PYRIDINYL]-4-OXO-1,4-- DIHYDRO-3-QUINOLINECARBOXYLIC ACID SALTS - There is provided a salt of 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid selected from the group consisting of citrate, hemi-fumarate, maleate, L-tartrate, mesylate, hydrochloride, potassium, and sodium salts. | 02-14-2013 |
20120184594 | PHENYLPYRROLIDINE COMPOUNDS - This invention provides new phenylpyrrolidine compounds, their use for the treatment or prevention of melatoninergic disorders and its compositions. | 07-19-2012 |
20110294769 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS - The invention relates to new steroids nitrooxyderivatives, to topical pharmaceutical formulations thereof, and their use for treating skin or mucosal membrane diseases or disorders. These new steroids nitrooxyderivatives have an improved pharmacological activity and enhanced local tolerability. | 12-01-2011 |
20110263646 | PHARMACEUTICAL TOPICAL COMPOSITIONS - The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream. | 10-27-2011 |
20110251251 | POLYMORPH II OF AN ANTIFUNGAL COMPOUND - The invention relates to a crystalline polymorph of a pharmaceutically acceptable salt of an optically active anti-fungal imidazole compound of formula (III), the pharmaceutical and agricultural compositions containing such polymorph, its use in the treatment or prevention of skin or mucous membrane infections caused by fungi or yeasts in humans or pets, and its use in the treatment or prevention of agricultural diseases produced by such infectious agents. | 10-13-2011 |
20110152333 | 3-CYANOPYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS - The invention provides new oxazolidinone compounds of formula (I) wherein R | 06-23-2011 |
20110144178 | 1 ,6-DIHYDRO-2H-3-OXA-6-AZA-AS-INDACENE COMPOUNDS - The invention provides new compounds of formula (I) wherein R | 06-16-2011 |
20110136829 | 3-(N-HETEROCYCLYL)-PYRROLIDINYL-PHENYL-OXAZOLIDINONES AS ANTIBACTERIAL AGENTS - The invention provides new oxazolidinone compounds of formula (I) wherein R, R | 06-09-2011 |
20110086094 | CAPSULE FOR THE PREVENTION OF CARDIOVASCULAR DISEASES - The invention relates to a capsule for the prevention of cardiovascular diseases which comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated tablets of lisinopril, ramiphl or perindopril. The capsules are used for the prevention of cardiovascular diseases in high-risk populations. | 04-14-2011 |
20100168099 | 1H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS - The invention provides new 1H-quinolin-4-one compounds of formula (I), wherein R | 07-01-2010 |
20100087451 | POLYMORPH B OF N--N-METHYL-ACETAMIDE - The present invention relates to a novel polymorph of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide, processes for its preparation, its use as a medicament, its use in the manufacture of a medicament, and pharmaceutical compositions comprising the novel polymorph. | 04-08-2010 |
20090264394 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS - The invention relates to new steroids nitrooxyderivatives, to topical pharmaceutical formulations thereof, and their use for treating skin or mucosal membrane diseases or disorders. These new steroids nitrooxyderivatives have an improved pharmacological activity and enhanced local tolerability. | 10-22-2009 |
20090258849 | NITROOXY DERIVATIVES OF GLUCOCORTICOIDS - The invention relates to new steroids nitrooxyderivatives, to topical pharmaceutical formulations thereof, and their use for treating skin or mucosal membrane diseases or disorders. These new steroids nitrooxyderivatives have an improved pharmacological activity and enhanced local tolerability. | 10-15-2009 |
20090196922 | BILAYER TABLET FOR PREVENTING CARDIOVASCULAR EVENTS - The present invention relates to a bilayer tablet which comprises a compartment containing a pharmaceutically acceptable simvastatin compound as its active ingredient; and at the same time a separate compartment containing a pharmaceutically acceptable lisinopril compound and a pharmaceutically acceptable folic acid compound as active ingredients, for the prevention of stroke in high-risk conditions or diseases. | 08-06-2009 |
20090176777 | Imidazo (1,2-a)Pyridin-3-YL-Acetic Acid Hydrazides, Proesses for Their Preparation and Pharmaceutical Uses Thereof - The invention provides novel imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides of formula (I) wherein R | 07-09-2009 |
20090111848 | Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates - The invention provides novel halogenated pyrazolo[1,5-a]pyrimidines of formula (I) wherein R, R | 04-30-2009 |
20090062266 | OXAZOLIDINONE COMPOUNDS, AND COMPOSITIONS AND METHODS RELATED THERETO - The invention provides new oxazolidinone compounds of formula (I) wherein A is certain heterocycles optionally substituted; R | 03-05-2009 |
20090005573 | Method for Manufacturing Imidazole Compounds and Salts and Pseudopolymorphs Thereof - The invention relates to a method for manufacturing sertaconazole mononitrate. The invention also relates tcserta-conazole mononitrate that is characterized by it: particle size and to sertaconazole mononitrate monohydrate. | 01-01-2009 |
20090005566 | Method for Making 1-Substituted 1H-Imidazo [4,5-C] Quinolin-4-Amine Compounds and Intermediates Therefor - The present invention concerns a method for manufacturing 1-substituted 1H imidazo[4,5-c]quinolin-4-amine compounds through their corresponding formamides. The invention also concerns new formamide intermediates. | 01-01-2009 |
20080206158 | Benzoic Acid Ester Compounds, Compositions, Uses and Methods Related Thereto - Benzoic acid ester compounds of formula (I): | 08-28-2008 |
20080200473 | Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto - The present invention relates to novel imidazo[1,2-a]pyridine compounds of general formula (I): | 08-21-2008 |